Adding Mitomycin To Bacillus Calmette-Guerin As Adjuvant Intravesical Therapy For High-Risk, Nonmuscle-Invasive Urothelial Bladder Cancer (Bcgmm; Anzup 1301)

Elizabeth Chien Hern Liow,Dickon Hayne,Martin R. Stockler,Andrew James Martin,Shomik Sengupta,Paul Anderson,Kate Ford,Mark Frydenberg,Margot Gorzeman,Will Green,Jeremy Grummet,Cynthia Hawks,Laurence Eliot Miles Krieger,Joseph Ischia,Steve McCombie,Manish Patel,Ian D. Davis,New Zealand Urogenital

JOURNAL OF CLINICAL ONCOLOGY（2020）

Cited 1|Views7

No score

Abstract

TPS602Background: Adjuvant intravesical bacillus Calmette-Guerin (BCG) decreases disease recurrence and progression in people with high-risk, non-muscle invasive urothelial bladder cancer (NMIBC), ...

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined